Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies
Clinical trial NCT07014319 · RECRUITING
Trial details
- NCT number
- NCT07014319
- Sponsor
- Seoul National University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-03
- Primary completion
- 2027-10-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.